Infusion Pumps Receive FDA Attention in New Initiative


FDA attention to infusion pumps

New FDA Initiative on Infusion Pumps

FDA initiated a new effort to make infusion pumps, medical devices that deliver fluids including drugs, safer and more accurate. The initiative shows the attention that FDA is paying to patient safety. It includes a new draft guidance document released for comment. There have been a number of articles commenting about the infusion pumps that refer to “requirements” being issued by FDA. An example is from Medpage Today. There is a link at the bottom of the post to their article. However, this isn’t exactly the case. A “draft guidance document” is basically a preliminary recommendation. FDA is not issuing a “proposed rule” that would become a regulation that FDA can actually enforce. Please see the link to the Blog Compliance Zen at the bottom of this post that also discusses this issue.

This specific draft guidance document does in fact reference medical device regulations. However, it manages to use the words “recommend” and “must” (as in requirement) in the same paragraph describing information needed by FDA to evaluate the medical device:

infusion pumps FDA

Infusion Pumps are Necessary for Advancements in Diabetes Technology

“We recommend you identify your device by the regulation and product code described in Section 3, Scope. You must provide information on how your device is similar to and/or different from other products of comparable type in commercial distribution, accompanied by data to support the statement, as required by 21 CFR 807.87(f). Side by side comparisons, whenever possible, are desirable.”

These are some of the issues involved with developing an “Artificial Pancreas” that the blog has discussed in previous posts:

First Artificial Pancreas Article

More on the Artificial Pancreas

For hospitalized patients, diabetics, and those with chronic pain this isn’t a moot point. The question of infusion pump safety can quite literally be a question of life or death.

infusion pump FDA

What Approach: Recommendations or Requirements?

Is this the best approach? Will an infusion pump manufacturer need to follow this recommendation? Or will it lead to confusion on what is actually required and allow inadequate descriptions of the infusion pumps in a medical device 510(k) application. The 510(k) application does not carry the same extensive requirements as an investigational device exemption (IDE) application.

There are a number of things that can go wrong with infusion pumps. Many are controlled with software. FDA issued these comments about potential software problems:

“Unfortunately, in some cases, the software does “go wrong” and compromises patient safety. Because software is inevitably complex, abstract, and intangible, design errors can be difficult to detect. Users and patients should expect infusion pump software to be free from errors. The occurrence of a software error should be a highly unusual event.”

FDA attention infusion pumps

Should Reviewing & Writing New Regulations be an FDA Priority?

I am glad that FDA is giving attention to the issue of infusion pumps. There is a good deal of information besides the draft guidance document that will benefit consumers who need to pay attention to infusion pumps. Again, I notice that FDA begins a major consumer protection initiative on a Friday, when it will receive the least attention. They did the same thing in announcing issues with Simvastatin (see previous post). FDA has also decided to take on this issue with a guidance document, not a regulation. Many of FDA’s regulations are antiquated and in serious need of updating. What to do about software and computer validation is certainly one of the issues that FDA needs to take on.

Part 11- Electronic Records; Electronic Signatures, has been in limbo since 2003. Part 312, the investigational new drug (IND) regulations haven’t had a major review since the 1980s. And the medical device regulations in Part 812 and 814 have received substantial public criticism.

Public health initiatives are a very good thing. Sometimes, however, you need a regulation that can be enforced.

Here is a link to the Infusion Pump Initiative

UPDATE: Here is a link to Compliance Zen that has an excellent post by John Avellanet on “Regulation by Guidance” that discusss this issue. Compliance Zen was recently selected as one of the top 50 blogs for biotech students (see Blogroll).

The New York Times has an extensive article on the topic

Here is the article from Medpage Today

Share/Bookmark

UPDATE: You can now “Like” the Blog on Facebook. They no longer have fans, which I think is an improvement:

GxP Perspectives LinkedIn Group

2 Responses to Infusion Pumps Receive FDA Attention in New Initiative

  1. Minard says:

    I?m not sure where you’re getting your information, but great topic. I needs to spend some time learning much more or understanding more. Thanks for great info I was looking for this information for my mission.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: